Related Experiment Video
Updated: Jan 27, 2026

A Bioinformatics Pipeline for Investigating Molecular Evolution and Gene Expression using RNA-seq
Published on: May 28, 2021
Investigation of Key Genes and Pathways in Inhibition of Oxycodone on Vincristine-Induced Microglia Activation by
Wei Liu1, Jishi Ye2, Hong Yan1
1Department of Anesthesiology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China.
Introduction:
The neurobiological mechanisms underlying the chemotherapy-induced neuropathic pain are only partially understood. Among them, microglia activation was identified as the key component of neuropathic pain. The aim of this study was to identify differentially expressed genes (DEGs) and pathways associated with vincristine-induced neuropathic pain by using bioinformatics analysis and observe the effects of oxycodone on these DEG expressions in a vincristine-induced microglia activation model.
Methods:
Based on microarray profile GSE53897, we identified DEGs between vincristine-induced neuropathic pain rats and the control group. Using the ToppGene database, the prioritization DEGs were screened and performed by gene ontology (GO) and signaling pathway enrichment. A protein-protein interaction (PPI) network was used to explore the relationship among DEGs. Then, we built the vincristine-induced microglia activation model and detected several DEG expressions by real-time polymerase chain reaction (PCR) and western blotting. Meanwhile, the effects of different concentrations of oxycodone on inflammatory response in primary microglia induced by vincristine were observed.
Results:
A total of 38 genes were differentially expressed between normal and vincristine-treated rats. GO and pathway enrichment analysis showed that prioritization DEGs are involved in cAMP metabolic process, inflammatory response, regulation of cell proliferation, and chemokine pathway. The in vitro studies showed that vincristine had dose-dependent cytotoxic effects in microglia. Compared to the control group, vincristine (0.001 μg/ml) could lead to inflammation in primary microglia induced by vincristine and upregulated the CXCL10, CXCL9, SFRP2, and PF4 mRNA and made an obvious reduction in IRF7 mRNA. At protein levels, oxycodone (50, 100 ng/ml) decreased the expression of CXCL10 and CXCL9 in activated microglia.
Conclusion:
Our study obtained several DEG expressions and signaling pathways in the vincristine-induced neuropathic pain rat model by bioinformatics analysis. Oxycodone could alleviate the vincristine-induced inflammatory signaling in primary microglia and downregulate some DEGs. Further molecular mechanisms need to be explored in the future.
Insights
This study identifies genes and pathways involved in chemotherapy-induced neuropathic pain. Oxycodone was found to reduce inflammation in microglia, suggesting a potential therapeutic role in managing chemotherapy side effects.
Area of Science:
- Neuroscience
- Pharmacology
- Genomics
Background:
- Chemotherapy-induced neuropathic pain (CINP) mechanisms are not fully understood.
- Microglia activation is a key factor in neuropathic pain development.
- Vincristine is a common chemotherapeutic agent known to cause neuropathic pain.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) and pathways in vincristine-induced neuropathic pain using bioinformatics.
- To investigate the effects of oxycodone on these DEGs in a vincristine-induced microglia activation model.
Main Methods:
- Microarray analysis (GSE53897) to identify DEGs in vincristine-treated rats.
- Bioinformatic tools (ToppGene, GO, pathway enrichment, PPI network) for DEG prioritization and analysis.
- In vitro modeling of vincristine-induced microglia activation, followed by real-time PCR, western blotting, and oxycodone treatment.
Main Results:
- 38 DEGs identified between normal and vincristine-treated rats.
- Enriched pathways include cAMP metabolism, inflammatory response, cell proliferation regulation, and chemokine signaling.
- Vincristine induced dose-dependent inflammation in microglia, upregulating CXCL10, CXCL9, SFRP2, PF4, and downregulating IRF7 mRNA.
- Oxycodone reduced CXCL10 and CXCL9 protein expression in activated microglia.
Conclusions:
- Bioinformatics analysis revealed key DEGs and pathways in vincristine-induced neuropathic pain.
- Oxycodone demonstrates potential to alleviate vincristine-induced inflammatory signaling in microglia by downregulating specific DEGs.
- Further research is warranted to elucidate the precise molecular mechanisms.
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Organization of Genes
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

